This process is critically mediated by lipoprotein lipase (LPL) and the fatty acid translocase CD36, ultimately leading to reduced plasma lipid levels and conferring protection against atherosclerosis in hyperlipidaemic models [47]. This evidence concerns the gene CD36 and atherosclerosis.